Published in Stroke on April 08, 2004
The potential utility of blood-derived biochemical markers as indicators of early clinical trends following severe traumatic brain injury. World Neurosurg (2013) 1.46
D-dimer as a predictor of progressive hemorrhagic injury in patients with traumatic brain injury: analysis of 194 cases. Neurosurg Rev (2010) 1.02
Molecular biomarkers in stroke diagnosis and prognosis. Biomark Med (2009) 0.92
Correlation between Serum D-Dimer Level and Volume in Acute Ischemic Stroke. J Korean Neurosurg Soc (2011) 0.89
Plasma D-dimer levels are associated with stroke subtypes and infarction volume in patients with acute ischemic stroke. PLoS One (2014) 0.87
Contraction of Blood Clots Is Impaired in Acute Ischemic Stroke. Arterioscler Thromb Vasc Biol (2016) 0.81
Population-based study of blood biomarkers in prediction of subacute recurrent stroke. Stroke (2014) 0.81
Predictors of early neurological deterioration in patients with acute ischaemic stroke with special reference to blood urea nitrogen (BUN)/creatinine ratio & urine specific gravity. Indian J Med Res (2015) 0.80
Assessment of Serum UCH-L1 and GFAP in Acute Stroke Patients. Sci Rep (2016) 0.79
Mechanisms, predictors and clinical impact of early neurological deterioration: the protocol of the Trondheim early neurological deterioration study. BMC Neurol (2014) 0.79
The prognostic value of biomarkers in stroke. Immun Ageing (2016) 0.79
Vitamin D & endothelial function. Indian J Med Res (2014) 0.79
Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic stroke. Neural Regen Res (2013) 0.77
Silent New Brain Lesions: Innocent Bystander or Guilty Party? J Stroke (2015) 0.77
Plasma D-dimer predicts short-term poor outcome after acute ischemic stroke. PLoS One (2014) 0.77
A quantitative trait locus on chromosome 5p influences d-dimer levels in the san antonio family heart study. Int J Vasc Med (2010) 0.76
Thrombin Generation and Atherothrombosis: What Does the Evidence Indicate? J Am Heart Assoc (2016) 0.76
Developing and validating a predictive model for stroke progression. Cerebrovasc Dis Extra (2011) 0.75
Serum C-reactive protein, fibrinogen and D-dimer in patients with progressive cerebral infarction. Transl Neurosci (2016) 0.75
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet (2002) 17.19
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med (2004) 15.30
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet (2010) 14.24
Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial. Lancet (2015) 7.16
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet (2005) 5.51
Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. JAMA (2010) 5.10
Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet (2008) 4.70
Comprehensive geriatric assessment for older adults admitted to hospital: meta-analysis of randomised controlled trials. BMJ (2011) 4.34
Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med (2008) 4.34
Effects of augmented exercise therapy time after stroke: a meta-analysis. Stroke (2004) 3.83
Comprehensive geriatric assessment for older adults admitted to hospital. Cochrane Database Syst Rev (2011) 3.71
C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes (2002) 3.59
Lifecourse influences on health among British adults: effects of region of residence in childhood and adulthood. Int J Epidemiol (2007) 3.15
Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation (2010) 2.78
Physical activity and hemostatic and inflammatory variables in elderly men. Circulation (2002) 2.75
Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet (2006) 2.72
Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis. Cancer Causes Control (2008) 2.68
Comprehensive geriatric assessment for older hospital patients. Br Med Bull (2005) 2.64
C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation (2005) 2.53
Association of C-reactive protein with blood pressure and hypertension: life course confounding and mendelian randomization tests of causality. Arterioscler Thromb Vasc Biol (2005) 2.42
An analysis of prospective risk factors for aortic stiffness in men: 20-year follow-up from the Caerphilly prospective study. Hypertension (2010) 2.40
European Stroke Initiative Recommendations for Stroke Management-update 2003. Cerebrovasc Dis (2003) 2.35
Associations of vitamin C status, fruit and vegetable intakes, and markers of inflammation and hemostasis. Am J Clin Nutr (2006) 2.24
Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J (2005) 2.21
Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts. Int J Epidemiol (2008) 2.14
Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis. Br J Haematol (2005) 2.10
Do acute phase markers explain body temperature and brain temperature after ischemic stroke? Neurology (2012) 2.03
Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data. Arch Intern Med (2008) 2.01
Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis. Arthritis Res Ther (2006) 1.96
Inflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstream. PLoS Med (2008) 1.95
Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study. Circulation (2005) 1.89
Occupational therapy for patients with problems in personal activities of daily living after stroke: systematic review of randomised trials. BMJ (2007) 1.85
Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery Study. Circulation (2007) 1.85
Uncovering treatment burden as a key concept for stroke care: a systematic review of qualitative research. PLoS Med (2013) 1.79
Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ (2008) 1.78
Gender differences in the cross-sectional relationships between sleep duration and markers of inflammation: Whitehall II study. Sleep (2009) 1.77
Barthel index for stroke trials: development, properties, and application. Stroke (2011) 1.68
Early discharge hospital at home. Cochrane Database Syst Rev (2009) 1.67
Noninvasive cardiac event monitoring to detect atrial fibrillation after ischemic stroke: a randomized, controlled trial. Stroke (2013) 1.66
Association between C-reactive protein genotype, circulating levels, and aortic pulse wave velocity. Hypertension (2008) 1.64
Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS Med (2009) 1.63
Adipokines and risk of type 2 diabetes in older men. Diabetes Care (2007) 1.63
D-dimer predicts early clinical progression in ischemic stroke: confirmation using routine clinical assays. Stroke (2006) 1.60
Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study. Eur Heart J (2004) 1.60
Adipocytokines and risk of stroke in older people: a nested case-control study. Int J Epidemiol (2008) 1.59
The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes. Int J Epidemiol (2011) 1.58
Relationship between progression of brain white matter changes and late-life depression: 3-year results from the LADIS study. Br J Psychiatry (2012) 1.57
Impaired endogenous thrombolysis in acute coronary syndrome patients predicts cardiovascular death and nonfatal myocardial infarction. J Am Coll Cardiol (2010) 1.56
Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events? PLoS Med (2009) 1.54
Blood biomarkers for the diagnosis of acute cerebrovascular diseases: a prospective cohort study. Cerebrovasc Dis (2011) 1.53
Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis. Eur Heart J (2013) 1.53
Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study. Arch Intern Med (2007) 1.52
A consensus on stroke: early supported discharge. Stroke (2011) 1.52
Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population. Circulation (2007) 1.47
Extent of regression dilution for established and novel coronary risk factors: results from the British Regional Heart Study. Eur J Cardiovasc Prev Rehabil (2004) 1.47
Pravastatin and cognitive function in the elderly. Results of the PROSPER study. J Neurol (2009) 1.47
Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study. Eur Heart J (2007) 1.47
Cognitive decline and markers of inflammation and hemostasis: the Edinburgh Artery Study. J Am Geriatr Soc (2007) 1.46
Genome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2. Arterioscler Thromb Vasc Biol (2014) 1.45
C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Circulation (2007) 1.43
Medical day hospital care for older people versus alternative forms of care. Cochrane Database Syst Rev (2015) 1.42
N-terminal pro-brain natriuretic peptide and cognitive decline in older adults at high cardiovascular risk. Ann Neurol (2014) 1.41
Services for reducing duration of hospital care for acute stroke patients. Cochrane Database Syst Rev (2012) 1.41
Association of novel genetic Loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts. Circ Cardiovasc Genet (2009) 1.41
2001-2011: A Decade of the LADIS (Leukoaraiosis And DISability) Study: What Have We Learned about White Matter Changes and Small-Vessel Disease? Cerebrovasc Dis (2011) 1.40
How far to investigate older people? Clin Med (2003) 1.39
Predictors of upper limb recovery after stroke: a systematic review and meta-analysis. Clin Rehabil (2011) 1.37
Interventions for improving upper limb function after stroke. Cochrane Database Syst Rev (2014) 1.34
Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes (2009) 1.34